International Cardiovascular Research Journal
The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences
Outlines
Prevention of Venous Thromboembolism in Major Orthopedic Surgery: Bayesian Network Meta-Analysis of 21 Randomized Trials Evaluating Unfractionated Heparins, Low-Molecular Weight Heparins, and New Oral Anticoagulants
Abstract
References
- 1.The references are available in PDF.
Copyright
© 2017, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Comparison of Dabigatran vs. Warfarin in Acute Vnous Thromboemboly: Systematic Review
Ganji R, Ala S, Aarabi M, Baghery B, Salehifar E. Comparison of Dabigatran vs. Warfarin in Acute Vnous Thromboemboly: Systematic Review. Iran J Pharm Res. 2016;15(2):e125175. doi: https://doi.org/10.22037/ijpr.2016.1867
Enoxaparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke
Duy KN, Nguyen DT, Le MV, Le LD, Tran HC, et al. Enoxaparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke. J Adv Immunopharmacol. 2022;2(1):e122415. doi: https://doi.org/10.5812/tms-122415
Comparison of Efficacy and Safety of Two Different Enoxaparin Products in Prevention of Venous Thromboembolism Following Major Obstetric-gynecological Surgeries: An Open-label Randomized Clinical Trial
Abdolvand M, Aleyasin A, Javadi MR, Solduzian M, Hosseini SH, et al. Comparison of Efficacy and Safety of Two Different Enoxaparin Products in Prevention of Venous Thromboembolism Following Major Obstetric-gynecological Surgeries: An Open-label Randomized Clinical Trial. Iran J Pharm Res. 2019;18(4):e124707. doi: https://doi.org/10.22037/ijpr.2019.111902.13417
Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial
Alavi-Darazam I, Forouhar K, Moradi O, Saffaei A, Asadi S, et al. Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial. Iran J Pharm Res. 2022;21(1):e126555. doi: https://doi.org/10.5812/ijpr-126555
New Oral Anticoagulants in Acute Coronary Syndrome: Is There Any Advantage Over Existing Treatments?
Messori A, Fadda V, Gatto R, Maratea D, Trippoli S. New Oral Anticoagulants in Acute Coronary Syndrome: Is There Any Advantage Over Existing Treatments?. Int Cardiovasc Res J. 2017;8(3):e11104. doi:
Crossmark
Checking
- Scopus by DOI: 0
Last Update: 1 month ago
- Scopus by Title: 0
Last Update: 1 month ago
- Scopus by Title (Ref): 0
Last Update: 1 month ago
- CrossRef: 0
Last Update: 1 day ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):